Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age0-90

SponsorZhejiang University

About this trial

This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.

clinically diagnosed as IPMN;

without other malignant tumor;

agree to sign informed consent.

with mental disorders which can affect cognition and cooperation;

with serious blood diseases or taking drugs that can affect peripheral blood

5,000 Participants

are divided into 1 treatment group

Zhejiang University

Lead sponsor

The Second Hospital of Hebei Medical University

Collaborator

Second Affiliated Hospital of Nanchang University

Collaborator

Meng Chao Hepatobiliary Hospital of Fujian Medical University

Collaborator

Huizhou Municipal Central Hospital

Collaborator